Clinical Trial Update: Allogeneic Human Mesenchymal Stem Cells for Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for allogeneic human mesenchymal stem cells in Alzheimer dementia is ongoing with an unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Dementia
• Alzheimer Disease

Drugs mentioned

• Allogeneic human mesenchymal stem cells (Mesenchymal stem cells)

Snippet

Sponsor: Stemedica Cell Technologies, Inc. | Conditions: Alzheimer Dementia | Phase 2 | Status: UNKNOWN